After R&D, real estate costs are among the most significant expenses for life sciences companies. From sophisticated laboratories and compliant manufacturing facilities to modern offices with flexible workplaces—optimized and efficient real estate portfolios are required to uphold business goals while supporting the bottom line. Learn the 3 trends CRE executives say are affecting corporate real estate in the life science industry, based on the report: Rewriting the code of Life Sciences CRE - 2014 Corporate Real Estate Trends for the Life Sciences Sector.

1. Rewriting the code of Life Sciences CRE
2014 Corporate Real Estate Trends for the Life Sciences Sector

2. Rewriting the code of Life Sciences CRE
Corporate Real Estate Trends for the Life Sciences Sector
1

3. CRE success hampered by a disconnect with the C-suite
Fragmented structure, combined with a lack of communication with the C-Suite, affect the CRE
relationship with other corporate functions and limit its alignment with global strategic objectives
2
Decentralization of CRE function limits its value-add to the organization
Major constraints hindering CRE from enhancing its strategic position

4. Strong demands for portfolio optimization
Portfolio efficiency demands represent a major challenge for CRE teams
Demands related to portfolio efficiency, costs and flexibility are the most critical and are
expressed to a higher degree than in most other sectors
3
Senior leadership demands being placed on CRE

5. Regional portfolio reshuffle
Shift toward emerging markets requires a review of real estate strategy
Over a third of life sciences companies anticipate reducing or consolidating their
real estate portfolios in European markets, while 63% and 48% plan to increase their
portfolios in China and Brazil, respectively
4
Net portfolio growth anticipated over the next three years

6. Challenges leading to opportunities
Life Sciences CRE transformation
5
Expansion to
emerging markets
Demands for
portfolio optimization
Business
environment challenges
Regulations
Patent cliff
Pricing pressures
Structural risks
Disconnect with C-suite
Fragmented teams
Limited collaboration with
other corporate functions
Life Sciences CRE
transformation
Re-organization of
CRE teams for better
alignment with business
Senior leadership
support / change of
reporting structure
Closer collaboration
with other corporate
functions

7. 2014 Corporate Real Estate Trends for the Life Sciences Sector
Interested?
Intrigued?
>> Download your
free copy of the full
report
Rewriting the code of Life Sciences CRE